Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
St. Jude Children’s Research Hospital offers a 12-month specialized Residency in Medication-Use Safety. This particular residency program is in its second year of enrolling residents and is currently in ASHP candidate status.
The St. Jude Medication-Use Safety residency program is a postgraduate training program that provides advanced training in medication safety and medication use policy. The purpose of the program is to prepare the resident to excel in leading medication safety and medication use policy in complex health systems. The institution’s commitment to providing comprehensive patient care, full integration of an electronic medical record that applies to inpatient and outpatient care, and the highly skilled clinical pharmacy team provide unrivalled opportunities for direct involvement in improving medication safety. The complex and high risk nature of treatment provided at St. Jude provides a unique learning environment for patient safety and quality that can be later applied to any health care setting.
Throughout the program, the resident will gain experience in medication error and adverse drug event reporting and investigation processes, lead medication safety assessment and improvement efforts to prevent future events and reactions, and work to maximize the patient safety benefits of the electronic medical record. Other activities may include newsletter writing, policy and guideline development, formulary management, and experience with a fully integrated electronic medical record. The resident will participate in Root Cause Analysis, serve on the Medication Use Safety Team and attend the Pharmacy & Therapeutics Committee.
Along with medication safety experiences, the resident will acquire experience in teaching through lectures, in-services, journal club presentations and precepting pharmacy students on rotation. The resident will be expected to complete a research project focused on medication safety and present the results at a national meeting. Upon completion of this residency, the individual will be well equipped to function as a Mediation Use Safety Officer in a health-system setting.
The resident, after completing orientation, will spend approximately 9 months of the 12-month program focusing on improving medication use practices. The resident will have the opportunity to participate in both administrative as well as patient care aspects of the St. Jude medication use process. Potential one- or two-month elective rotation experiences are available for the Medication-Use Safety resident but will be based on longitudinal, research and other project responsibilities within the program. Elective rotation choices for the Medication-Use Safety resident are similar to that of the Pediatric Hematology/Oncology Residency PGY2 program list, and may also include time with a corporate Medication Safety Officer in a large university hospital and visits to national organizations devoted to safe medication use.
January 11, 2013 at 5:00 PM (CST)
Please note, beginning with the 2013-2014 residency year all applicants will be required to submit application materials to PhORCAS.
James M. Hoffman, PharmD, MS, BCPS
Medication Outcomes and Safety Officer
Associate Member, Pharmaceutical Sciences
St. Jude Children's Research Hospital
262 Danny Thomas Place
Mail Stop 150
Memphis, TN 38105-3678
Phone: (90) 595-5767
FAX: (901) 595-3111